Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia

BACKGROUND: Several clinical trials have demonstrated the efficacy of fluconazole as empiric antifungal therapy in cancer patients with fever and neutropenia. Our objective was to assess the frequency and resource utilization associated with treatment failure in cancer patients given empiric flucona...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Donghui T, Seger, Diane L, Peterson, Josh F, Kumar, Ritesh N, Bates, David W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702543/
https://www.ncbi.nlm.nih.gov/pubmed/17147804
http://dx.doi.org/10.1186/1471-2334-6-173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702543/
https://www.ncbi.nlm.nih.gov/pubmed/17147804
http://dx.doi.org/10.1186/1471-2334-6-173

Ejemplares similares